Franklin M. Berger - Nov 11, 2022 Form 4 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Role
Director
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Franklin M. Berger
Stock symbol
AVIR
Transactions as of
Nov 11, 2022
Transactions value $
-$214,685
Form type
4
Date filed
11/15/2022, 07:00 PM
Previous filing
Nov 14, 2022
Next filing
Nov 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVIR Common Stock Sale -$131K -25.5K -3.11% $5.15 795K Nov 11, 2022 Direct F1, F2
transaction AVIR Common Stock Sale -$83.4K -16.2K -2.03% $5.16 778K Nov 14, 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.1200 to $5.1947, inclusive.
F2 The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.1000 to $5.2242, inclusive.